1993
DOI: 10.1148/radiology.188.1.8511286
|View full text |Cite
|
Sign up to set email alerts
|

Noninvasive quantitative fluorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curve.

Abstract: The authors have developed a technique to estimate input functions from a population-based arterial blood curve in positron emission tomography (PET) studies with fluorine-18 fluorodeoxyglucose (FDG). A standardized pump injection was used in 34 subjects. A population-based blood curve was generated based on the first 10 subjects. In the remaining 24 subjects, an estimated input function (EIFa) was obtained by scaling the population-based curve with two arterial blood samples, one obtained at 10 minutes and th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
153
0
1

Year Published

1996
1996
2016
2016

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 183 publications
(155 citation statements)
references
References 11 publications
1
153
0
1
Order By: Relevance
“…For tracers with metabolites, PBIF refers to the serial concentrations over time of the parent radioligand separated from radiometabolites. Population-based input function has been validated mostly for [ 18 F]-FDG, using arterial (Takikawa et al, 1993) or venous blood samples (Takagi et al, 2004) as scaling factors, or using noninvasive individual parameters such as body surface area (Shiozaki et al, 2000) or cerebellar [ 18 F]-FDG activity (Bentourkia, 2006). Studies with other PET tracers are very rare (Beattie et al, 2010;Cook et al, 1999;Takikawa et al, 1994).…”
Section: Why Does a Methods Work For One Tracer But Not Another?mentioning
confidence: 99%
“…For tracers with metabolites, PBIF refers to the serial concentrations over time of the parent radioligand separated from radiometabolites. Population-based input function has been validated mostly for [ 18 F]-FDG, using arterial (Takikawa et al, 1993) or venous blood samples (Takagi et al, 2004) as scaling factors, or using noninvasive individual parameters such as body surface area (Shiozaki et al, 2000) or cerebellar [ 18 F]-FDG activity (Bentourkia, 2006). Studies with other PET tracers are very rare (Beattie et al, 2010;Cook et al, 1999;Takikawa et al, 1994).…”
Section: Why Does a Methods Work For One Tracer But Not Another?mentioning
confidence: 99%
“…A population-averaged FDG blood curve (calculated for monkey) was scaled to the measured blood curve for the time period from injection to the end of the PET scan (Takikawa et al, 1993). Data were transformed to CMRglc based on the operational equation (Sokoloff et al, 1977;Phelps et al, 1979).…”
Section: Methodsmentioning
confidence: 99%
“…Dynamic PET data collection was not feasible in our system because of its step-andshoot acquisition protocol. This limitation has been addressed in a next-generation system, 42 where investigators could optionally employ a population-based arterial input function 45 or arterial blood sampling. Kinetic parameters thus derived could reveal new knowledge about RA or PsA pathogenesis.…”
Section: Fluorine-18 Fludeoxyglucose Uptake For the First Carpometacamentioning
confidence: 99%